Bulletin
Investor Alert

Teva Pharmaceutical Industries Ltd. ADR

NYS: TEVA

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Teva Pharmaceutical Industries Ltd. ADR

After Hours

TEVA
/zigman2/quotes/205657894/composite

$

8.47

Change

-0.06 -0.70%

Volume

Volume 1.58m

Mar 23, 2023, 7:58 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/205657894/composite

Previous close

$ 8.73

$ 8.53

Change

-0.20 -2.29%

Day low

Day high

$8.40

$8.83

Open
Open: 8.76

52 week low

52 week high

$6.78

$11.45

Open

Market cap

$9.96B

Average volume

8.73M

P/E ratio

N/A

Rev. per Employee

$404,986

EPS

-2.12

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/teva

MarketWatch News on TEVA

  4. Teva names former Sandoz chief Richard Francis as new CEO

    8:16 a.m. Nov. 21, 2022

    - Steve Gelsi

  5. Teva Pharmaceutical names pharma exec Richard Francis and president and CEO

    8:05 a.m. Nov. 21, 2022

    - Steve Gelsi

  6. New Teva CEO Richard Francis was CEO of Sandoz and Biogen exec

    8:05 a.m. Nov. 21, 2022

    - Steve Gelsi

  7. Teva CEO Kåre Schultz to retire on Dec. 31

    8:05 a.m. Nov. 21, 2022

    - Steve Gelsi

  8. Teva Pharmaceutical downgraded to underweight from neutral at J.P. Morgan

    7:45 a.m. Nov. 14, 2022

    - Tomi Kilgore

  9. Teva Is 'on the Way' to Leaving Opioid Litigation Behind, CEO Says

    12:28 p.m. Nov. 3, 2022

    - Barron's Online

  13. Teva Pharmaceutical upgraded to buy from neutral at BofA Securities

    9:44 a.m. Aug. 5, 2022

    - Tomi Kilgore

  15. $4.4 Billion Opioid Settlement Gives Teva Stock a Boost

    3:32 a.m. July 28, 2022

    - Barron's Online

  16. Teva Stock Soars After Reaching $4.25 Billion Opioid Settlement

    6:14 a.m. July 27, 2022

    - Barron's Online

  19. Teva to pay $75 mln over 15 years to settle opioid claims from W. Va., plus pay $8 mln in legal fees

    9:46 a.m. May 25, 2022

    - Steve Gelsi

  20. Teva settlement with W. Va. also includes $27 mln worth of generic Narcan over 10 years

    9:46 a.m. May 25, 2022

    - Steve Gelsi

  21. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/teva

Other News on TEVA

  1. McKinsey Consulted VA While Advising Opioid Makers to Target Agency for Sales

    2:32 a.m. March 14, 2023

    - The Wall Street Journal Interactive Edition

  2. Francisco Garcia Parames' Cobas Funds 4th-Quater Letter

    6:01 p.m. Feb. 22, 2023

    - GuruFocus.com

  3. Top 5 4th Quarter Trades of BECK MACK & OLIVER LLC

    7:00 a.m. Feb. 18, 2023

    - GuruFocus.com

  4. Top 5 4th Quarter Trades of MILLER VALUE PARTNERS, LLC

    1:00 a.m. Feb. 18, 2023

    - GuruFocus.com

  5. Top 5 3rd Quarter Trades of Exor Capital LLP

    3:00 p.m. Feb. 16, 2023

    - GuruFocus.com

  6. Top Trades of David Abrams' Firm in the 4th Quarter

    4:54 p.m. Feb. 13, 2023

    - GuruFocus.com

  7. Opioid Settlement Money Is Coming. Two Ohio Counties Differ on How to Spend It.

    3:34 a.m. Feb. 14, 2023

    - The Wall Street Journal Interactive Edition

  8. 10-K: TEVA PHARMACEUTICAL INDUSTRIES LTD

    8:06 a.m. Feb. 10, 2023

    - Edgar Online - (EDG = 10Q, 10K)

  9. Humira Faces Competition From First U.S. Copycat

    7:23 a.m. Feb. 1, 2023

    - The Wall Street Journal Interactive Edition

  10. DEA Pressed ADHD-Drug Makers About Impact of Telehealth Firms on Surging Demand

    11:20 a.m. Dec. 31, 2022

    - The Wall Street Journal Interactive Edition

  12. World’s Top-Selling Drug Going Off Patent Means Big Bucks for Middlemen

    4:21 a.m. Nov. 28, 2022

    - The Wall Street Journal Interactive Edition

  14. Teva Pharmaceutical Names Richard Francis as CEO

    3:32 a.m. Nov. 22, 2022

    - The Wall Street Journal Interactive Edition

  15. Opioid reversal agent naloxone approvable for OTC use – FDA

    2:37 p.m. Nov. 15, 2022

    - Seeking Alpha

  16. Top 5 3rd Quarter Trades of DSC Advisors, L.P.

    9:00 a.m. Nov. 15, 2022

    - GuruFocus.com

  18. Teva slips as JPMorgan downgrades on growth concerns

    10:01 a.m. Nov. 14, 2022

    - Seeking Alpha

  20. BECK MACK & OLIVER LLC Buys 2, Sells 3 in 3rd Quarter

    7:00 p.m. Nov. 10, 2022

    - GuruFocus.com

  21. Loading more headlines...
/news/pressrelease/company/us/teva

Press Releases on TEVA

  1. Teva Pharmaceutical $TEVA Pivots Trading Plans and Risk Controls

    6:58 a.m. March 22, 2023

    - Stock Traders Daily

  3. Teva Pharmaceutical $TEVA Investment Report

    3:39 p.m. March 12, 2023

    - Stock Traders Daily

  7. Teva to Present at the Barclays Global Healthcare Conference

    5:00 p.m. March 7, 2023

    - BusinessWire - BZX

  8. Teva Pharmaceutical ($TEVA) Trading Report

    12:59 a.m. March 3, 2023

    - Stock Traders Daily

  17. Teva Pharmaceutical TEVA Trading Report

    6:36 p.m. Feb. 11, 2023

    - Stock Traders Daily

  19. Teva Reports Fourth Quarter and Full Year 2022 Financial Results

    8:00 a.m. Feb. 8, 2023

    - BusinessWire - BZX

  21. Loading more headlines...

Rates »

Mortgage Equity Savings Auto
Link to MarketWatch's Slice.